Industry News
Common parasite genome sequenced
The genome of the Trichomonas vaginalis parasite, responsible for a common sexually transmitted disease, has been sequenced. [ + ]
Lung cancer vaccine trial begins recruitment
Australian hospitals will be involved in a global Phase III clinical trial of a potential cancer vaccine. [ + ]
Rapid DNA testing
University of Rochester Chemistry Department researchers have developed a method for rapidly testing DNA. The method can be used to help forensics labs identify criminals, test ponds and pools before children swim in them, and identify harmful genetic sequences in medical research, to name only a few applications. The procedure quickly and inexpensively identifies genetic sequences in any sample of DNA.
[ + ]Leading cancer researcher is new bioscience boss
Professor Brandon Wainwright, cancer and cystic fibrosis researcher, is the new director of an Australian bioscience flagship, the Institute for Molecular Bioscience (IMB) at the University of Queensland (UQ).
[ + ]New methods to visualise live cells
The US-based Cold Spring Harbor Laboratory has released two new, freely accessible protocols to help scientists understand the movement and growth of cells. [ + ]
Molecular detail on influenza epitopes
A comprehensive analysis of influenza A epitopes, the critical sites on the virus that are recognised by the immune system, has been published by researchers from California's La Jolla Institute for Allergy and Immunology (LIAI). [ + ]
Research into procrastination shows surprising findings
A University of Calgary professor in the Haskayne School of Business has recently published his magnum opus on the subject of procrastination – and it''s only taken him 10 years.
[ + ]Nutrition studies' conclusions tied to funding source
A systematic analysis of the medical literature shows that nutrition studies'' conclusions correlate with who funds them – much like the bias found for pharmaceutical studies, but with potentially greater public health implications.
[ + ]Applications for BIO award close soon
Applications for the Advancing BioBusiness Award, being piloted by drug company Merck Sharpe & Dohme (MSD) and not-for-profit networking organisation Advance, close on 25 January, 2007. [ + ]
First prion-free cows reported
Hematech and Kirin Brewery Company have announced the production of healthy prion protein-knockout cows.
[ + ]Non-exclusive worldwide licence to use ddRNAi in research programs granted
Sigma-Aldrich, a life science and high technology company, has announced that it has granted Pfizer a worldwide non-exclusive research licence to use DNA-directed RNAi (ddRNAi) technology.
[ + ]Agreement for non-contact heart sensor
CSIRO has announced the signing of a licensing agreement with Melbourne-based bio-technology medical device company, HD Medical Group Limited, for commercial application of its non-contact sensor technology.
[ + ]Funding boost for banana research
A $5.1 million Queensland University of Technology research project that aims to improve the health of East Africans will be stepped up after a massive funding boost.
[ + ]Extracting ‘bioactives’ from agricultural and food processing streams
Transforming products from agricultural and food processing streams into health-enhancing ingredients for use in a variety of foods and nutraceuticals is the aim of a $7 million Flagship Collaboration Fund Cluster involving CSIRO’s Food Futures Flagship, Monash University and the University of Melbourne.
[ + ]Australian companies offered fast track opportunity
The Company Chemists Association has offered Australian companies the opportunity to attend New Frontiers 2007, business seminar and business speed dating event, which seeks to help international companies that are keen to expand into the United Kingdom pharmacy market to fast track their business and understanding of the market.
[ + ]
